Gilead Sciences (BUE:GILD) Land And Improvements : ARS0 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Gilead Sciences Land And Improvements?

Gilead Sciences's land and improvements for the quarter that ended in Mar. 2024 was ARS0 Mil.

Gilead Sciences's quarterly land and improvements increased from Sep. 2023 (ARS0 Mil) to Dec. 2023 (ARS202,521 Mil) but then declined from Dec. 2023 (ARS202,521 Mil) to Mar. 2024 (ARS0 Mil).

Gilead Sciences's annual land and improvements increased from Dec. 2021 (ARS40,800 Mil) to Dec. 2022 (ARS94,219 Mil) and increased from Dec. 2022 (ARS94,219 Mil) to Dec. 2023 (ARS202,521 Mil).

Gilead Sciences Land And Improvements Historical Data

The historical data trend for Gilead Sciences's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences Land And Improvements Chart

Gilead Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Land And Improvements

Get a 7-Day Free Trial

24,148.53

32,877.52

40,799.96

94,219.30

202,521.00

Gilead Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Land And Improvements	Get a 7-Day Free Trial															-	-	-	202,521.00	-

Gilead Sciences Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Gilead Sciences (BUE:GILD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (BUE:GILD) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

GILD:USA GILD:Mexico GILD:Italy GISd:UK 0QYQ:UK GIS:Germany GIS:Germany GIS:Germany GIS:Germany GILD34:Brazil GILD:Austria

Address

333 Lakeside Drive, Foster, CA, USA, 94404

Website

https://www.gilead.com

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.